Enjoying this bite?
Sign in (free) to track this channel, unlock new bites the moment they drop, and search every summary we've ever made.
Source: YouTube. Summary is AI-generated from the video's captions and may contain errors. It does not represent the views of TubeBite, the creator, or YouTube. Watch the original before relying on anything important.
SUMMARY
Parkev Tatevosian, CFA, analyzes UnitedHealth's integration of artificial intelligence in its operations and reviews the company's latest financial results. The discussion covers segment performance, pricing strategies, member trends, and a valuation assessment indicating potential undervaluation.
MAIN POINTS
- UnitedHealth is using AI in its Optum Express pharmacy business to reduce call center volume and improve member satisfaction.
- The customer service sector has seen widespread cost-cutting and automation, often resulting in poor user experiences.
- UnitedHealth's operating segments outperformed expectations, with Q1 adjusted earnings per share of $7.23 and total revenue of $111.7 billion.
- The company lost domestic members due to price increases and exited its international business, now focusing solely on the U.S. market.
- There are early signs of improved alignment between UnitedHealth's pricing and medical cost trends following previous miscalculations.
- A fair value calculation estimates UnitedHealth shares at $487, significantly above the current market price, suggesting undervaluation.
DETAILED ANALYSIS
UnitedHealth has implemented artificial intelligence within its Optum Express pharmacy business, resulting in a 25% reduction in call center volume and member satisfaction rates exceeding 95%. This application of AI targets a sector often plagued by underinvestment and cost-cutting, where customer service experiences have historically suffered due to automation and outsourcing. The company’s approach demonstrates how technology can address inefficiencies and improve user interactions in a field notorious for long wait times and repetitive information requests.
In the latest quarter, UnitedHealth’s operating segments collectively exceeded internal performance plans. The company reported adjusted earnings per share of $7.23, surpassing expectations, with total revenue reaching $111.7 billion for the quarter. Annualized, this positions UnitedHealth to achieve over $444 billion in revenue for the trailing twelve months, though growth was modest at 2%, primarily driven by price increases rather than volume expansion.
The company’s decision to raise prices resulted in a decline in domestic membership to 49.1 million, down from 49.8 million at the end of 2025, and was compounded by a complete exit from international markets to focus exclusively on the U.S. segment.
Despite the reduction in membership, UnitedHealth is beginning to see improved alignment between its pricing strategies and medical cost trends. This is a notable recovery from 2025, when costs outpaced the company’s pricing assumptions, leading to significant stock declines. For 2026, price increases have better matched cost trends, stabilizing the gap between revenue and expenses.
Looking ahead, free cash flow is projected to decline from a peak of $23 billion to an estimated trough of $18.18 billion in 2027, before resuming growth. The present value of anticipated future free cash flows is calculated at $443 billion. After adjusting for debt and non-operating assets, the estimated fair value per share stands at $487, well above the current market price of $367, indicating that UnitedHealth may be undervalued and present a potential buying opportunity.
LINKS
- Special offer for The Motley Fool Stock Advisor via Parkev Tatevosian.
- Parkev Tatevosian's book on a six-step investing framework.
- Fiscal.ai investment research platform with a discount for viewers.
- Parkev Tatevosian's Substack newsletter subscription.
- YouTube channel membership for exclusive perks and access to spreadsheets.